Mr Labeeb Abboud | General Counsel & SVP Business Development
International AIDS Vaccine Initiative

Mr Labeeb Abboud, General Counsel & SVP Business Development, International AIDS Vaccine Initiative

Labeeb M. Abboud is Senior Vice President and General Counsel of the International AIDS Vaccine Initiative, a non-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI’s activities include research and development, advocacy and public policy. IAVI is headquartered in New York, with regional offices in Amsterdam, Delhi, Johannesburg and Nairobi. In addition, IAVI operates AIDS vaccine research and development laboratories in New York City, La Jolla, California and London, and partners with a network of partner clinical research centers in Africa and India. Mr. Abboud is responsible for business development, legal, intellectual property and risk management activities, and advises the board on strategy and governance issues. He has experience in negotiating collaborations and licensing arrangements with pharmaceutical and biotechnology companies in the US, Europe, Asia and Africa, as well as partnerships and joint ventures with academic institutions and governments globally, designed to ensure an AIDS vaccine is made available and affordable promptly in developing countries. He has played a prominent role within the global health field in efforts to share best practices on business development and legal matters. Prior to joining IAVI, Mr. Abboud worked in the fields of international finance, corporate law and microfinance. He is a member of the Council on Foreign Relations, has served as a board member of a several environmental and educational non-profit organizations in the U.S. and Europe, and is a graduate of Wesleyan University and Georgetown University Law Center.

Share this

Appearances at this years' conference:

World Vaccine Partnering Congress Asia Day One - 12 June 2012


@ 09.00
Keynote Plenary: The role of Asia as an integral part of the global vaccine industry

  • Source of innovation, manufacturing destination or key growth market
  • Identifying the key advantages that Asia holds for the vaccine industry
  • Evaluating best practices to leverage on these advantages for an effective global strategy
     

  • › Mr Labeeb Abboud, General Counsel & SVP Business Development, International AIDS Vaccine Initiative

World Vaccine Partnering Congress Asia Day Two - 13 June 2012


@ 09.20
Identifying potential partnerships and executing them effectively across different Asian markets

  • IAVI’s successful partnerships across India, China and Japan
  • Overcoming challenges in public-private-partnerships
  • Identifying the right angle to partner with industry or research institutes

 

  • › Mr Labeeb Abboud, General Counsel & SVP Business Development, International AIDS Vaccine Initiative

World Vaccine Trials Congress Asia Day One - 12 June 2012


@ 09.00
Keynote Plenary: The role of Asia as an integral part of the global vaccine industry

  • Source of innovation, manufacturing destination or key growth market
  • Identifying the key advantages that Asia holds for the vaccine industry
  • Evaluating best practices to leverage on these advantages for an effective global strategy
     

  • › Mr Labeeb Abboud, General Counsel & SVP Business Development, International AIDS Vaccine Initiative

World Vaccine Manufacturing Congress Asia Day One - 12 June 2012


@ 09.00
Keynote Plenary: The role of Asia as an integral part of the global vaccine industry

  • Source of innovation, manufacturing destination or key growth market
  • Identifying the key advantages that Asia holds for the vaccine industry
  • Evaluating best practices to leverage on these advantages for an effective global strategy
     

  • › Mr Labeeb Abboud, General Counsel & SVP Business Development, International AIDS Vaccine Initiative
Sponsors
Platinum sponsor
GE Healthcare at World Vaccine Congress Asia 2012
Gold Sponsor
Merck Millipore at World Vaccine Congress Asia 2012
Silver Sponsor
Medicago Inc at World Vaccine Congress Asia 2012
Bronze sponsor
Finesse Solutions, LLC at World Vaccine Congress Asia 2012
Bronze Sponsor
ViroClinics Biosciences B.V. at World Vaccine Congress Asia 2012
Innovative showcase sponsor
Bavarian Nordic A/S at World Vaccine Congress Asia 2012
Innovative biotech showcase sponsor
Immune Targeting Systems (ITS) Ltd at World Vaccine Congress Asia 2012